Ocugen, Inc. (OCGN) vs Relmada Therapeutics, Inc. (RLMD)
A side-by-side comparison of Ocugen, Inc. and Relmada Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
OCGN
Ocugen, Inc.
$1.04HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
RLMD
Relmada Therapeutics, Inc.
$3.28HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — OCGN vs RLMD
growth of $100 · dividends reinvested · last 10yOCGN -99.4% (-40.4%/yr)RLMD +231.4% (+12.7%/yr)RLMD compounded faster over this window
Log scale — wide-divergence pair
OCGN RLMD
OCGN vs RLMD: by the numbers
- •OCGN is the larger company ($353M vs $344M market cap).
- •Both run net losses; RLMD's is the smaller (0.00% vs -1786.27% net margin).
Metrics side by side
Valuation
| Metric | OCGN | RLMD |
|---|---|---|
| P/S ratio | 77.00 | N/A |
| P/B ratio | N/A | 1.67 |
Profitability
| Metric | OCGN | RLMD |
|---|---|---|
| Gross margin | 45.86% | 0.00% |
| Operating margin | -1425.70% | 0.00% |
| Net margin | -1786.27% | 0.00% |
| ROE | N/A | -29.98% |
| ROIC | -93.74% | -30.78% |
Growth (annualized)
| Metric | OCGN | RLMD |
|---|---|---|
| Total return CAGR (5Y) | -31.57% | -7.68% |
Frequently asked
- How have OCGN and RLMD total returns compared?
- Over the past 10 years, OCGN delivered -40.73% and RLMD delivered 12.41% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.